In patients with IDH-mutated astrocytomas, the presence of CDKN2A/B homozygous deletion leads to clinical behavior consistent with that of CNS WHO grade 4 gliomas [3]. This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).